TScan Therapeutics

TScan Therapeutics (Nasdaq: TCRX) is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts developing T-cell receptor engineered T-cell (TCR-T) therapies for the treatment of patients with cancer. The company uses a high-throughput, genome-wide target-discovery platform to identify the TCRs and antigen targets that drive T-cell recognition of tumors, building a multiplexed library of TCR-T candidates (ImmunoBank) for both hematologic malignancies and solid tumors. Lead programs TSC-100 and TSC-101 target minor histocompatibility antigens to prevent disease relapse after allogeneic hematopoietic cell transplant. As a therapeutics company it exposes no public developer API surface; this profile captures its identity and probed domain-security posture for the API Evangelist network. Backed by Bessemer Venture Partners and GV.

TScan Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotech, Biopharmaceutical, Immunotherapy, and Cell Therapy.

🌐 Visit website 📡 Source on GitHub
7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechBiopharmaceuticalImmunotherapyCell TherapyOncologyTCR-TClinical StageLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/tscan-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Tscan Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: tscan-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/tscan-therapeutics.png
name: TScan Therapeutics
description: 'TScan Therapeutics (Nasdaq: TCRX) is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts
  developing T-cell receptor engineered T-cell (TCR-T) therapies for the treatment of patients with cancer. The company uses
  a high-throughput, genome-wide target-discovery platform to identify the TCRs and antigen targets that drive T-cell recognition
  of tumors, building a multiplexed library of TCR-T candidates (ImmunoBank) for both hematologic malignancies and solid tumors.
  Lead programs TSC-100 and TSC-101 target minor histocompatibility antigens to prevent disease relapse after allogeneic hematopoietic
  cell transplant. As a therapeutics company it exposes no public developer API surface; this profile captures its identity
  and probed domain-security posture for the API Evangelist network. Backed by Bessemer Venture Partners and GV.'
url: https://raw.githubusercontent.com/api-evangelist/tscan-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- bessemer-venture-partners
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotech
- Biopharmaceutical
- Immunotherapy
- Cell Therapy
- Oncology
- TCR-T
- Clinical Stage
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1
common:
- type: DomainSecurity
  url: security/tscan-therapeutics-domain-security.yml
- type: Website
  url: https://www.tscan.com